AB-Biotics SA (ABB):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AB-Biotics SA (ABB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7914
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprietary supplements, lysozyme and defensin peptides, and infantile colic products. It also provides pyloriosis, radiobal products, vitamin K products, lactobacillus brevis, natural solutions, neuropharmagen testing products, and probiosis products, among others. AB-Biotics offers services such as protocol development, drug development, clinical testing services, financing, research and development, microbiology services, and project execution services, among others. The company markets and supplies its products in Spain and abroad. AB-Biotics is headquartered in Barcelona, Spain.

AB-Biotics SA (ABB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AB-Biotics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AB-Biotics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AB-Biotics SA, Medical Equipment, Deal Details 10
Partnerships 10
CompanionDx Reference Labs Enters into Licensing Agreement with Ab-Biotics 10
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 11
AB-Biotics Enters into Co-Promotion Agreement with iLife Discoveries for Neurofarmagen 12
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 13
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 14
AB-Biotics Enters Into Commercialization Agreement With Almirall For Neurofarmagen 15
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
Equity Offering 17
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 17
Acquisition 18
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 18
AB-Biotics SA – Key Competitors 19
AB-Biotics SA – Key Employees 20
AB-Biotics SA – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
AB-Biotics SA, Medical Equipment, Key Facts, 2017 2
AB-Biotics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AB-Biotics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Deals By Market, 2012 to YTD 2018 8
AB-Biotics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CompanionDx Reference Labs Enters into Licensing Agreement with Ab-Biotics 10
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 11
AB-Biotics Enters into Co-Promotion Agreement with iLife Discoveries for Neurofarmagen 12
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 13
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 14
AB-Biotics Enters Into Commercialization Agreement With Almirall For Neurofarmagen 15
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 17
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 18
AB-Biotics SA, Key Competitors 19
AB-Biotics SA, Key Employees 20

List of Figures
AB-Biotics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AB-Biotics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AB-Biotics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AB-Biotics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AB-Biotics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AB-Biotics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AB-Biotics SA (ABB):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a provider of in revenue cycle management. The company offers patient engagement and SaaS-based solutions. Its portfolio of services includes Health Information Management (HIM), patient care, patient engagement, coding and Clinical Docu …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Faisal Islamic Bank of Egypt (SAE) (FAITA):企業の財務・戦略的SWOT分析
    Faisal Islamic Bank of Egypt (SAE) (FAITA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virolo …
  • Urenco Ltd:企業の戦略・SWOT・財務分析
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Exor N.V:企業の戦略・SWOT・財務分析
    Exor N.V - Strategy, SWOT and Corporate Finance Report Summary Exor N.V - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Summit Midstream Partners LP (SMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oklahoma Medical Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute. The institute conducts disease research for human diseases such as lupus, alzheimer’s and diseases of aging, diabetics, cancer, children’s disease, autoimmune disease and heart diseases. Its portfolio …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sygnis AG (LIO1)-医療機器分野:企業M&A・提携分析
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products inc …
  • Quaker Chemical Corp (KWR):企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Perfint Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products for onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a computed tomography system; ROBIO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆